Compare CNTB & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTB | SEVN |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.4M | 167.9M |
| IPO Year | 2020 | 2008 |
| Metric | CNTB | SEVN |
|---|---|---|
| Price | $0.90 | $6.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $5.88 | ★ $9.55 |
| AVG Volume (30 Days) | ★ 1.6M | 165.9K |
| Earning Date | 11-11-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 16.50% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | $64,000.00 | ★ $29,383,000.00 |
| Revenue This Year | $11,291.47 | $18.67 |
| Revenue Next Year | $74.30 | $12.98 |
| P/E Ratio | ★ N/A | $35.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.85 | $6.70 |
| 52 Week High | $3.82 | $10.90 |
| Indicator | CNTB | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.38 | 20.91 |
| Support Level | $0.85 | N/A |
| Resistance Level | $2.74 | $8.84 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 3.46 | 1.67 |
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.